Press Releases Novo Nordisk A/S Sao Paulo

Equities

N1VO34

BRN1VOBDR005

Market Closed - Sao Paulo Other stock markets 20:45:17 25/06/2024 BST			5-day change	1st Jan Change
99.98 ^BRL	+23.89%		+4.65%	+60.04%

06-25	Health Care Up as Novo Nordisk Gets China OK -- Health Care Roundup	DJ
06-25	Trending : Novo Nordisk's Wegovy Weight-Loss Drug Gets Chinese Approval	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	06-24	GL
Novo Nordisk A/S - share repurchase programme	06-24	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	06-18	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	06-18	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	06-17	AQ
Novo Nordisk A/S - share repurchase programme	06-17	GL
Haemophilia drug could reduce treated bleeding episodes	06-13	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	06-11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	06-11	AQ
Novo Nordisk A/S - share repurchase programme	06-10	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Novo Nordisk A/S - share repurchase programme	06-03	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Novo Nordisk A/S - share repurchase programme	05-27	GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	05-21	AQ
Novo Nordisk A/S - share repurchase programme	05-17	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	05-15	GL
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial	05-13	GL
Tampere University : Novo Nordisk Foundation grants 670 000 EUR to develop organ transplant assessment and drug discovery tool for epilepsy	05-13	AQ
Equity Research \| NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential	05-10	AQ